Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults

British Journal of Anaesthesia

Volumn 77, Issue 6, 1996, Pages 710-715

  Abdulatif, M ^a,c   Mowafi, H ^b   Al Ghamdi, A ^b   El Sanabary, M ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b KING FAISAL UNIVERSITY   (Saudi Arabia)

^c NONE   (Egypt)

Author keywords

Age factors; Anaesthesia, paediatric; Antagonists neuromuscular block, neostigmine; Neuromuscular block, rocuronium; Pharmacology, dose response

Indexed keywords

CHOLINESTERASE INHIBITOR; INHALATION ANESTHETIC AGENT; ISOFLURANE; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM;

ADULT; ARTICLE; CHILD; DOSE RESPONSE; DRUG ANTAGONISM; HUMAN; MAJOR CLINICAL STUDY; NEUROMUSCULAR BLOCKING; PEDIATRIC ANESTHESIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030451003     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.6.710     Document Type: Article

References (38)

1. Cook DR. Muscle relaxants in infants and children. Anesthesia and Analgesia 1981; 60: 335-343.
2. Fisher DM, Cronnelly R, Miller RD, Sharma M. The neuromuscular pharmacology of neostigmine in infants and children. Anesthesiology 1983; 59: 220-225.
3. Bevan JC, Purday JP, Reimer EJ, Bevan DR. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children. Canadian Journal of Anaesthesia 1994; 41: 1074-1080.
4. Bevan JC, Tousignant C, Stephenson C, Blackman L, Reimer E, Smith MF, Bevan DR. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children. Anesthesiology 1996; 84: 354-361.
5. Bevan DR, Kahwaji R, Ansermino J, Reimer E, Smith M, O'Connor G, Bevan JC. Residual block after mivacurium with or without edrophonium reversal in adults and children. Anesthesiology 1996; 84: 362-367.
6. Smith CE, Donati F, Bevan DR. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade. Anesthesiology 1989; 71: 37-43.
7. Naguib M, Abdulatif M, Al-Ghamdi A. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (Org 9426)-induced neuromuscular blockade. Anesthesiology 1993; 79: 739-745.
8. Debaene B, Meistelman C, d'Hollander A. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia. Anesthesiology 1989; 71: 840-844.
9. Cameron CB, Robinson S, Gregory GA. The minimum anesthetic concentration of isoflurane in children. Anesthesia and Analgesia 1984; 63: 418-420.
10. Zar J H. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, 1974; 151-162.
11. Naguib M, Abdulatif M. Dose-response relationships for edrophonium and neostigmine antagonism of pipecuronium-induced neuromuscular block. Anesthesia and Analgesia 1994; 78: 306-311.
12. Beemar GH, Bjorksten AR, Dawson PJ, Dawson RJ, Heenan PJ, Robertson BA. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. British Journal of Anaesthesia 1991; 66: 469-475.
13. Rupp SM, McChristian JW, Miller RD, Toboada JA, Cronnelly R. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium or vecuronium. Anesthesiology 1986; 64: 711-717.
14. Hennart D, d'Hollander A, Plasman C, DeJonckheere M. Importance of the level of paralysis recovery for a rapid antagonism of atracurium neuromuscular blockade with moderate doses of edrophonium. Anesthesiology 1986; 64: 384-387.
15. Meistelman C, Debaene B, d'Hollander A, Donati F, Saint-Maurice C. Importance of the level of paralysis for a rapid antagonism of vecuronium with neostigmine in children during halothane anesthesia. Anesthesiology 1988; 68: 97-99.
16. Dernovoi B, Agoston S, Barvais L, Baurain M, Lefebvre R, d'Hollander A. Neostigmine antagonism of vecuronium paralysis during fentanyl, halothane, isoflurane and enflurane anesthesia. Anesthesiology 1987; 66: 698-701.
17. Donati F, McCarrol SM, Antazaka C, McCready D, Bevan DR. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine. Anesthesiology 1987; 66: 471-476.
18. Koscielniak-Nielsen ZJ, Law-Min JC, Donati F, Bevan DR, Clement P, Wise R. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients. Anesthesia and Analgesia 1992; 74: 845-850.
19. Cronnelly R. Kinetics of anticholinesterases. Clinics in Anesthesiology 1985; 3: 315-328.
20. Crumrine RS, Yodlowski EH. Assessment of neuromuscular functions in infants. Anesthesiology 1981; 54: 29-32.
21. Fisher DM, O'Keefe C, Stanski DR, Cronnelly R, Miller RD, Gregory GA. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982; 57: 203-208.
22. Bush GH. Use of neuromuscular blockers in pediatric surgery and intensive care. Clinics in Anesthesiology 1985; 3: 405-420.
23. Head-Rapson AG, Hunter JM. Muscle relaxants in the extremes of age. Clinics in Anesthesiology 1994; 8: 501-522.
24. Donati F. Onset of action of relaxants. Canadian Journal of Anaesthesia 1988; 35: S52-S58.
25. Bevan JC, Donati F, Bevan DR. Attempted acceleration of the onset of action of pancuronium: effects of divided doses in infants and children. British Journal of Anaesthesia 1985; 57: 1204-1208.
26. Woelfel SK, Brandom BW, Cook RD, Sarner JB. Effects of bolus administration of Org-9426 in children during nitrous oxide-halothane anesthesia. Anesthesiology 1992; 76: 939-942.
27. 2O-halothane anesthesia. Anesthesiology 1992; 3A: A907.
28. Gencarelli PJ, Miller RD. Antagonism of Org NC45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine. British Journal of Anaesthesia 1982; 54: 53-56.
29. Bevan DR, Donati F, Kopman AF. Reversal of neuromuscular blockade. Anesthesiology 1992; 77: 785-805.
30. Naguib M. Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination. Anesthesiology 1994; 81: 388-395.
31. Tang J, Joshi GP, White PF. Comparison of rocuronium and mivacurium to succinylcholine during outpatient laparoscopic surgery. Anesthesia and Analgesia 1996; 82: 994-998.
32. Sarner JB, Brandom B, Woelfel SK, Dong M, Horn MC, Cook RC, McNulty BF, Foster VJ. Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesthesia and Analgesia 1989; 68: 116-121.
33. Szenohradszky J, Lau M, Brown R, Sharma ML, Fisher DM. The effects of neostigmine on twitch tension and muscle relaxant concentration during infusion of mivacurium or vecuronium. Anesthesiology 1995; 83: 83-87.
34. Baraka A, Wakid N, Mansour R, Haddad W. Effect of neostigmine and pyridostigmine on plasma cholinesterase activity. British Journal of Anaesthesia 1981; 53: 849-852.
35. Fonseca J, Chaudhry IA, Marin F, Halliday NJ, Radvany T, Bikhazi GB, Foldes FF. Mivacurium block: spontaneous and neostigmine or edrophonium-induced recovery in children. Anesthesia and Analgesia 1994; 78: S118.
36. Johnson RA, Harper NJN. Antagonism of moderate degrees of vecuronium-induced neuromuscular block by small doses of neostigmine. British Journal of Anaesthesia 1989; 62: 483-487.
37. Harper NJN, Wallace M, Hall IA. Optimum dose of neostigmine at two levels of atracurium-induced neuromuscular block. British Journal of Anaesthesia 1994; 72: 82-85.
38. Gill SS, Bevan DR, Donati F. Edrophonium antagonism of atracurium during enflurane anaesthesia. British Journal of Anaesthesia 1990; 64: 300-305.